North Dakota State Investment Board’s Medline Inc MDLN Stock Holding History

North Dakota State Investment Board’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$502K	Buy	+12,721	New	+$513K	0.02%	495

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

North Dakota State Investment Board's MDLN Position: Q2 2026 in Review

North Dakota State Investment Board opened a new position in Medline Inc (MDLN) in Q2 2026: 12,721 shares worth $502K. The stake represents 0.02% of the portfolio and ranks #495 among its holdings.

405 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

North Dakota State Investment Board held 12,721 shares of Medline Inc worth $502K as of Q2 2026.
Medline Inc was a new North Dakota State Investment Board position in Q2 2026.
Medline Inc made up 0.02% of North Dakota State Investment Board's portfolio in Q2 2026, its #495 holding.
405 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.